Therapeutic effect of angiostatin gene transfer in a murine model of endometriosis

American Journal of Pathology

Volumn 161, Issue 3, 2002, Pages 909-918

  Dabrosin, Charlotta ^a   Gyorffy, Steve ^a   Margetts, Peter ^a   Ross, Catherine ^b   Gauldie, Jack ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOGENESIS INHIBITOR; ANGIOSTATIN; ESTRADIOL; PROGESTERONE; SEX HORMONE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DYSMENORRHEA; DYSPAREUNIA; ENDOMETRIOSIS; FEMALE; FEMALE INFERTILITY; GENE TRANSFER; MOUSE; NONHUMAN; PELVIS PAIN SYNDROME; PRIORITY JOURNAL;

EID: 0036733660     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64251-4     Document Type: Article

References (40)

1. The effect of endometriosis and its radical laparoscopic excision on quality of life indicators
2. Endometriosis and infertility: A laparoscopic study of endometriosis among fertile and infertile women
3. Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy
4. Effects of endometriomas on oocyte quality, embryo quality, and pregnancy rates in in vitro fertilization cycles: A prospective, case-controlled study
5. Cancer risk after a hospital discharge diagnosis of endometriosis
6. Ovulation suppression for endometriosis (Cochrane review)
7. Current drug therapy recommendations for the treatment of endometriosis
8. Peritoneal endometriosis due to menstrual dissemination of endometrial tissues into the peritoneal cavity
9. Immunobiology of endometriosis
10. Effect of peritoneal fluid from endometriosis patients on endometrial stromal cell proliferation in vitro
11. In vitro expression of soluble and cell surface-associated CD44 on endometrial cells from women with and without endometriosis
12. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: A rationale for endometriotic invasiveness
13. Extracellular matrix remodelling in the endometrium and its possible relevance to the pathogenesis of endometriosis
14. Morphometric study of the stromal vascularization in peritoneal endometriosis
15. Angiogenesis in endometriosis and angiogenic factors
16. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids
17. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis
18. Vascular endothelial growth factor (VEGF) in endometriosis
19. Vascular endothelial growth factor and endometriotic angiogenesis
20. Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins
21. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
22. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
23. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis
24. Angiogenesis and angiogenesis inhibitors in cancer
25. Suppression of arthritis and protection from bone destruction by treatment with TNP-470/AGM-1470 in a transgenic mouse model of rheumatoid arthritis
26. Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice
27. Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis
28. Circulating concentrations of FSH, LH, estradiol, and progesterone associated with acute, male-induced puberty in female mice
29. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3
30. Combined treatment of a murine breast cancer model with type 5 adenovirus vectors expressing murine angiostatin and IL-12: A role for combined anti-angiogenesis and immunotherapy
31. Age-correlated and ovary-dependent changes in relationships between plasma estradiol and luteinizing hormone, prolactin, and growth hormone in female C57BL/6J mice
32. Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity
33. Fluctuation of serum leptin level in rats after ovariectomy and the influence of estrogen supplement
34. Genetic heterogeneity of angiogenesis in mice
35. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470
36. Possible role of ovarian epithelial inflammation in ovarian cancer
37. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer
38. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis
39. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer
40. Metabolism of rabbit angiostatin glycoforms I and II in rabbits: Angiostatin-I leaves the intravascular space faster and appears to have greater anti-angiogenic activity than angiostatin-II